FTK · Flotek Industries, Inc. · Stock research

Current Thesis

The leg being bought is a pivot away from oilfield chemistry into measurement, control and distributed power. In Q2 2026 (reported 2026-08-04) the Data Analytics segment produced 51% of total gross profit against Chemistry's 49% — the first quarter that mix inverted — on segment revenue of $19.2M, up 223% YoY. One day earlier, on 2026-08-03, Flotek disclosed a 10-year contract supporting a 400 MW gas-fired project for the Puerto Rico Electric Power Authority with approximately $400M of expected revenue backlog and roughly $40M of annual revenue at full deployment. The market re-rated the whole company on the second business: the shares closed $35.42 on 2026-08-07, 2.8% under the 52-week closing high of $36.43, after a 121.8% three-month advance, with RSI(14) at 71.5.

Both catalysts that produced the move have already printed. The question the next two quarters answer is whether PWRtek converts a single utility award into a repeatable contract stream, or whether 2026 is a chemistry-cycle year wearing a power-infrastructure label.

Bullish and bearish views on Flotek Industries, Inc.

The model's bull view on Flotek Industries, Inc. (FTK), in brief: Q2 2026 (2026-08-04): EPS $0.26 vs $0.12 consensus; revenue $99.367M vs $67.720M consensus. The bear view: The re-rating has outrun the published targets. Both cases follow in full.

Bull Case

• Q2 2026 (2026-08-04): EPS $0.26 vs $0.12 consensus; revenue $99.367M vs $67.720M consensus. A 47% revenue beat is not a rounding difference in estimates — it is a business the sell-side was not modelling.
• FY2026 guidance raised to $340–350M revenue and $47–51M adjusted EBITDA, from $270–290M and $36–41M (2026-08-04). Prior consensus stood at $285.25M. The raised range explicitly excludes PREPA revenue, which the company expects to begin in Q1 2027.
• PREPA award (2026-08-03): up to 40 MW of PWRtek primary generation capacity plus up to six pairs of smart conditioning/distribution skids inside a 400 MW project, delivered with partner Power Expectations LLC. Support equipment deployment is guided to Q4 2026; initial generation and skids by end of Q1 2027.
• Installed-base math is visible, not promised: 89 XSPCT digital valuation units deployed or on order versus 25 active units at year-end 2025, against a company-identified addressable set of more than 200,000 US deployment locations (Q2 2026 materials).
• Chemistry is growing into a shrinking market. US frac fleets averaged 182 in Q2 2026 versus 192 a year earlier, while domestic chemistry revenue rose 43% and international chemistry hit $10.6M, up 172% YoY — a single quarter that matched 94% of full-year 2025 international revenue.
• The balance sheet is not the constraint: net debt $45.5M at 2026-06-30 with leverage at 0.9x, down from 1.1x at year-end 2025. Adjusted EBITDA of $16.8M in the quarter more than doubled from $8.0M.

Bear Case

• The re-rating has outrun the published targets. Five analysts carry a consensus price target of $36.92 (Simply Wall St, 2026-08-07) against a $35.42 close; JonesTrading's $40, initiated 2026-07-09, is the high mark on the tape. Consensus 2026 revenue was lifted to $333M and EPS to $0.77, but the price has already absorbed that revision.
• Related-party revenue is structural. Of the $19.2M Data Analytics quarter, $7.1M was related-party — the ProFrac relationship remains embedded in the segment now carrying the story.
• PREPA is a government counterparty with a long history of debt restructuring under federal oversight. Contracted backlog is an expectation of revenue, not a receivable; nothing bills until equipment is in service, and the first tranche is guided to Q4 2026.
• Guidance excludes the thing the stock re-rated on. FY2026 has to be carried entirely by chemistry and existing analytics work; PREPA cannot rescue a Q3 or Q4 shortfall.
• Capital intensity is rising with the unit count. Going from 25 active analyzers to 89 deployed-or-on-order is a working-capital and capex event; the company's own Q2 deck put market cap at $846M on 2026-06-30 against $1.28B on 2026-08-07 — an equity window that did not exist six weeks ago.

Setup & Price Structure

Close $35.42 on 2026-08-07, down 2.77% on the session, against a 52-week closing high of $36.43 and a 12-month low of $10.95. Three-month return 121.8%; RSI(14) 71.5, above the overbought threshold and rising into the print rather than after it. Beta 1.48 on 36.22M shares outstanding — a float small enough that single headlines move the whole capitalisation, which is what happened across 2026-08-03 and 2026-08-04.

Positioning observables, stated as observables: the consensus price target sits essentially at spot, so the sell-side provides no headroom without further estimate revisions; retail-facing coverage clustered heavily in the 2026-08-03 to 2026-08-05 window (deal, beat, guidance raise, sympathy movers lists); the shares closed the most recent session lower despite no negative company news, the first distribution day since the catalysts. No Form 4 activity and no registration statement appear in the trailing 30-day filing feed for this name — an issuance into strength, if it comes, shows up there first.

Structurally, price is consolidating within 3% of its high after a vertical move, with no base built at these levels. The mid-$20s is where this traded before 2026-08-03.

Catalyst Calendar (next 30 days)

• 2026-08-17 to 2026-08-19 — EnerCom Denver energy investment conference. Coverage of the Q2 release listed Flotek among scheduled presenters; the specific slot is unconfirmed here. First venue for management commentary on the PREPA deployment schedule outside the print.
• ~2026-11-03 (est.) — Q3 2026 results. Outside the 30-day window, and the next hard test of the $340–350M FY guide.
• ~2026-12-31 (est.) — PREPA support equipment deployment, guided to Q4 2026. No fixed date disclosed.

Nothing else inside 30 days is hard-dated. That is the current condition of the name: the catalysts are behind it and the next binary is roughly three months out.

What Would Change Our Mind

The fastest break is schedule slip. PREPA support equipment is guided to Q4 2026 with initial generation and skids by end of Q1 2027; if the Q3 print in early November carries no deployment confirmation, or pushes first revenue past Q1 2027, the $400M backlog reverts to a press release and the multiple loses its justification. A second break is inside the segment mix: Data Analytics reaching 51% of gross profit is the whole re-rating, and a sequential decline in that line — particularly a fall in the $7.1M related-party component — would say the inflection was a single quarter.

On the tape, the gradeable condition is a weekly close below $28, which would mean the market has largely un-priced the 2026-08-03 award and the 2026-08-04 raise while the guidance itself is unchanged. A trim to the FY2026 revenue range at the Q3 print would confirm the fundamental version of the same break.

Correlation Notes

• Pressure pumping / frac activity remains the chemistry demand driver, and it is contracting: 182 average US frac fleets in Q2 2026 versus 192 a year earlier. Domestic chemistry grew 43% against that, so the correlation to fleet count has loosened but not broken.
• ProFrac is the related party behind $7.1M of Q2 Data Analytics revenue; its activity levels and capex flow through both segments.
• Distributed gas power and grid-resilience names are the new comp set. The PREPA award and the company's stated ambition to support roughly 5 GW through measurement or control by Q1 2027 place FTK in the same flow as behind-the-meter and grid-enhancement equipment, which trades on power-demand headlines rather than on oil.
• Small-cap high-beta momentum: 36.22M shares and beta 1.48 mean the name amplifies risk-on and risk-off in the Russell complex independently of anything in its own income statement.